secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cyclo Therapeutics, Inc. (—)
CIK:        0000922247
Form:       8-K
Filed at:   2023-12-28T23:59:59+00:00
Accession:  0001437749-23-035495
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 3.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cyclo Therapeutics increases authorized common shares from 50M to 250M after stockholder approval
--------------------------------------------------------------------------------

- Stockholders approved increase in authorized common shares from 50M to 250M at special meeting Dec 26, 2023.
- Company filed Certificate of Amendment with Nevada Secretary of State on Dec 26, 2023, effective same day.
- The share increase could dilute existing shareholders; management's intended use of additional shares is not disclosed.
- Other proposals approved at special meeting described in prior 8-K filed Dec 26, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/922247/000143774923035495/0001437749-23-035495-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/922247/000143774923035495/ctdh20231228_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-035495

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer